AIM: To assess the outcome of patients with acute necrotizing pancreatitis treated by percutaneous drainage with special focus on the influence of drainage size and number. METHODS: We performed a retrospective analysis of 80 patients with acute pancreatitis requiring percutaneous drainage therapy for infected necroses. Endpoints were mortality and length of hospital stay. The influence of drainage characteristics such as the median drainage size, the largest drainage size per patient and the total drainage plane per patient on patient outcome was evaluated. RESULTS: Total hospital survival was 66%. Thirty-four patients out of all 80 patients (43%) survived acute necrotizing pancreatitis with percutaneous drainage therapy only. Eighteen patients out of all 80 patients needed additional percutaneous necrosectomy (23%). Ten out of these patients required surgical necrosectomy in addition, 6 patients received open necrosectomy without prior percutaneous necrosectomy. Elective surgery was performed in 3 patients receiving cholecystectomy and one patient receiving resection of the parathyroid gland. The number of drainages ranged from one to fourteen per patient. The drainage diameter ranged from 8 French catheters to 24 French catheters. The median drainage size as well as the largest drainage size used per patient and the total drainage area used per patient did not show statistically significant influence on mortality. CONCLUSION: Percutaneous drainage therapy is an effective tool for treatment of necrotizing pancreatitis. Large bore drainages did not prove to be more effective in controlling the septic focus.
AIM: To assess the outcome of patients with acute necrotizing pancreatitis treated by percutaneous drainage with special focus on the influence of drainage size and number. METHODS: We performed a retrospective analysis of 80 patients with acute pancreatitis requiring percutaneous drainage therapy for infected necroses. Endpoints were mortality and length of hospital stay. The influence of drainage characteristics such as the median drainage size, the largest drainage size per patient and the total drainage plane per patient on patient outcome was evaluated. RESULTS: Total hospital survival was 66%. Thirty-four patients out of all 80 patients (43%) survived acute necrotizing pancreatitis with percutaneous drainage therapy only. Eighteen patients out of all 80 patients needed additional percutaneous necrosectomy (23%). Ten out of these patients required surgical necrosectomy in addition, 6 patients received open necrosectomy without prior percutaneous necrosectomy. Elective surgery was performed in 3 patients receiving cholecystectomy and one patient receiving resection of the parathyroid gland. The number of drainages ranged from one to fourteen per patient. The drainage diameter ranged from 8 French catheters to 24 French catheters. The median drainage size as well as the largest drainage size used per patient and the total drainage area used per patient did not show statistically significant influence on mortality. CONCLUSION: Percutaneous drainage therapy is an effective tool for treatment of necrotizing pancreatitis. Large bore drainages did not prove to be more effective in controlling the septic focus.
Authors: J Gmeinwieser; A Holstege; H Zirngibl; K D Palitzsch; S Hügl; M Strotzer; S Feuerbach; J Schölmerich Journal: Gastrointest Endosc Date: 2000-09 Impact factor: 9.427
Authors: G Srikanth; Sadiq S Sikora; Sanjay S Baijal; Archana Ayyagiri; Ashok Kumar; Rajan Saxena; Vinay K Kapoor Journal: ANZ J Surg Date: 2002-12 Impact factor: 1.872
Authors: S Connor; N Alexakis; M G T Raraty; P Ghaneh; J Evans; M Hughes; C J Garvey; R Sutton; J P Neoptolemos Journal: Surgery Date: 2005-05 Impact factor: 3.982
Authors: A M Echenique; D Sleeman; J Yrizarry; T Scagnelli; J J Guerra; V J Casillas; H Huson; E Russell Journal: J Vasc Interv Radiol Date: 1998 Jul-Aug Impact factor: 3.464
Authors: Christopher C Stahl; Jonathan Moulton; Doan Vu; Ross Ristagno; Kyuran Choe; Jeffrey J Sussman; Shimul A Shah; Syed A Ahmad; Daniel E Abbott Journal: Surgery Date: 2015-08-10 Impact factor: 3.982
Authors: Janneke van Grinsven; Hjalmar C van Santvoort; Marja A Boermeester; Cornelis H Dejong; Casper H van Eijck; Paul Fockens; Marc G Besselink Journal: Nat Rev Gastroenterol Hepatol Date: 2016-03-09 Impact factor: 46.802
Authors: Janneke van Grinsven; Sandra van Brunschot; Olaf J Bakker; Thomas L Bollen; Marja A Boermeester; Marco J Bruno; Cornelis H Dejong; Marcel G Dijkgraaf; Casper H van Eijck; Paul Fockens; Harry van Goor; Hein G Gooszen; Karen D Horvath; Krijn P van Lienden; Hjalmar C van Santvoort; Marc G Besselink Journal: HPB (Oxford) Date: 2015-12-20 Impact factor: 3.647